Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials for 4D Molecular Therapeutics
Explore 9 clinical trials worldwide
Search
Showing 1-9 of 9 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Sponsor: 4D Molecular Therapeutics
Clinical Trials (9)
NCT07064759
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
PHASE3
Recruiting
400 participants
Started: Jul 22, 2025 · Completed: Feb 28, 2029
1 condition
1 sponsor
24 locations
NCT06864988
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
PHASE3
Recruiting
400 participants
Started: Mar 3, 2025 · Completed: Jun 30, 2028
1 condition
1 sponsor
99 locations
NCT05930561
4D-150 in Patients With Diabetic Macular Edema
PHASE2
Active, not recruiting
72 participants
Started: Aug 9, 2023 · Completed: Feb 28, 2029
2 conditions
1 sponsor
6 locations
NCT05629559
4D-310 in Adults With Fabry Disease and Cardiac Involvement
PHASE1/PHASE2
Recruiting
18 participants
Started: Oct 16, 2022 · Completed: Jun 30, 2030
1 condition
1 sponsor
4 locations
NCT05248230
4D-710 in Adult Patients With Cystic Fibrosis
PHASE1/PHASE2
Recruiting
40 participants
Started: Mar 29, 2022 · Completed: Jan 31, 2030
1 condition
1 sponsor
19 locations
NCT05197270
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
PHASE1/PHASE2
Recruiting
215 participants
Started: Dec 9, 2021 · Completed: Jan 31, 2031
1 condition
1 sponsor
24 locations
NCT04519749
An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry Disease
PHASE1/PHASE2
Active, not recruiting
18 participants
Started: Sep 1, 2020 · Completed: Jun 30, 2030
1 condition
1 sponsor
4 locations
NCT04517149
4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)
PHASE1/PHASE2
Active, not recruiting
21 participants
Started: Jun 9, 2020 · Completed: May 31, 2029
1 condition
1 sponsor
8 locations
NCT04483440
Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia
PHASE1
Active, not recruiting
13 participants
Started: Jun 2, 2020 · Completed: Aug 31, 2027
1 condition
1 sponsor
2 locations